| Intrinsic Valuation of: CCEP | |||||||||||
| Free Cash Flow Average and Growth over past 5Y | Key Statistics | ||||||||||
| Year | FCF | FCF (FCF/Revenue) | |||||||||
| 2020 | - | - | EPS (FY) | 5 | Market Cap | $40B | |||||
| 2021 | - | - (-) | P/E Ratio | 18 | Total Asset | $30B | |||||
| 2022 | $2B | - (-) | Net Income | $2B | Total Debt | $10B | |||||
| 2023 | $2B | -14.4% (-19.0%) | EBITDA | $4B | Total Liab | $22B | |||||
| 2024 | $2B | 6.4% (-4.7%) | Opr Margin | 13.36 | Debt/Equity | 1.17 | |||||
| 2025 | $2B | -5.6% (-7.7%) | PreTax Margin | 12.05 | BV/Share | -21 | |||||
| 5Y Average FCF | $2B | 3.5% (-10.5%) | |||||||||
| Overall Market Assumptions: | |||||||||||
| Assumptions: | P/E for No-Growth Company: | 7.0 | |||||||||
| Perpetual Growth Rate (g): | 2.48% | Historical US Bond Yield: | 4.40% | ||||||||
| Discount Rate (WACC): | 7.00% | Current US Bond Yield: | 3.48% | ||||||||
| Forcasting Future Free Cash Flow for next 6Y | Modified Benjamin Graham's Intrinsic Value | ||||||||||
| Year | FCF Projection (3.5%) | ||||||||||
| 2026 | $2B | MBG Intrinsic Value | $45 | ||||||||
| 2027 | $2B | ||||||||||
| 2028 | $2B | ||||||||||
| 2029 | $2B | ||||||||||
| 2030 | $2B | ||||||||||
| 2031 | $2B | ||||||||||
| Terminal Value | $55B | Net Worth/Share | $19 | ||||||||
| DCF Valuation | DCF Valuation "What If" Scenario Table | ||||||||||
| Enterprise Value | $47B | Growth Rate | |||||||||
| (+) Cash & Cash Equivalents | $918M | $87 | 1.5% | 2.0% | 2.5% | 3.0% | 3.5% | ||||
| (-) Total Debt | $10B | WACC | 6.5% | 81 | 90 | 101 | 115 | 134 | |||
| Equity Value | $39B | 7.1% | 70 | 76 | 85 | 95 | 108 | ||||
| Shares Outstanding | 442,777,049 | 7.8% | 61 | 66 | 72 | 80 | 89 | ||||
| 8.4% | 53 | 57 | 62 | 68 | 75 | ||||||
| DCF Intrinsic Value | $87 | 9.0% | 47 | 51 | 54 | 59 | 64 | ||||
| Analyzed by QuantJuice (2025) | |||||||||||